Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.
Tyler D HitchmanGabriella BayshtokEmilie CeraudoAmanda R MooreCindy LeeRuobing JiaNaitao WangMohini R PachaiAlexander N ShoushtariJasmine H FrancisYouxin GuanJuliet ChenMatthew T ChangBarry S TaylorThomas P SakmarThomas HuberPing ChiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
These data suggest that the combination of Gαq and MEK inhibition provides a promising therapeutic strategy and improved therapeutic window of broadly targeting Gαq in uveal melanoma.See related commentary by Neelature Sriramareddy and Smalley, p. 1217.